NASHUA, N.H., Oct. 29, 2015 (GLOBE NEWSWIRE) -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three months and nine months ended September 30, 2015.
Third Quarter Highlights:
* Total revenue of $9.6 million, a decrease of 23.8% year-over year, driven by the general uncertainty related to reimbursement for non-melanoma skin cancer treatment in the United States
* Cancer Detection revenue of $5.2 million, an increase of 5.4% year-over-year, including 17.6% product revenue growth
Help employers find you! Check out all the jobs and post your resume.
Third Quarter Highlights:
* Total revenue of $9.6 million, a decrease of 23.8% year-over year, driven by the general uncertainty related to reimbursement for non-melanoma skin cancer treatment in the United States
* Cancer Detection revenue of $5.2 million, an increase of 5.4% year-over-year, including 17.6% product revenue growth
Help employers find you! Check out all the jobs and post your resume.
